Prophylaxis against possible human immunodeficiency virus exposure after nonoccupational needlestick injuries or sexual assaults in children and adolescents

Archives of Pediatrics and Adolescent Medicine

Volumn 155, Issue 6, 2001, Pages 680-682

  Babl, Franz E ^a,b   Cooper, Ellen R ^a   Kastner, Beth ^a   Kharasch, Sigmund ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; INDINAVIR; LAMIVUDINE; NELFINAVIR; RITONAVIR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ARTICLE; HEALTH CARE POLICY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEEDLESTICK INJURY; PRIORITY JOURNAL; PROPHYLAXIS; PUBLIC HEALTH SERVICE; SEXUAL CRIME;

EID: 0035006045     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.155.6.680     Document Type: Article

References (19)

1. Centers for Disease Control and Prevention. Update: provisional public health service recommendations for chemoprophylaxis after occupational exposure to HIV. MMWR Morb Mortal Wkly Rep. 1997;45:468-472.
2. Centers for Disease Control and Prevention. Public Health Service guidelines for the management of health care worker exposure to HIV and recommendations for post-exposure prophylaxis. MMWR Morb Mortal Wkly Rep. 1998;47(RR-7):1 -33.
3. Katz HM, Geberding JL. Post-exposure treatment of people exposed to the HIV through sexual contact or injection drug use. N Engl J Med. 1997;336:1097-1100.
4. Katz MH, Geberding JL. The care of persons with recent sexual exposure to HIV. Ann Intern Med. 1998;128:306-312.
5. Centers for Disease Control and Prevention. Management of possible injecting-drug-use, or other non-occupational exposure to HIV, including considerations related to antiretroviral therapy. MMWR Morb Mortal Wkly Rep. 1998;47(RR-17):1-14.
6. American Academy of Pediatrics. 2000 Red Book: Report of The Committee ion Infectious Diseases. 25th ed. Elk Grove Village, III: American Academy of Pediatrics; 2000.
7. Babl FE, Cooper ER, Damon B, et al. HIV postexposure prophylaxis for children and adolescents. Am J Emerg Med. 2000;18:282-287.
8. Tsai CC, Follis KE, Sabo A, et al. Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethdoxypropyl)adenine. Science. 1995;270:1197-1199.
9. Shih CC, Kaneshima H, Rabin L, et al. Post-exposure prophylaxis with zidovudine suppresses human immunodeficiency virus type 1 infection in SCID-hu mice in a time-dependent manner. J Infect Dis. 1991;163:625-627.
10. Tsai C-C, Emau P, Folis KE, et al. Effectiveness of postinoculation with (R)-9-(2-phosphonylmethoxypropyl)adenine. Science. 1995;270:1197-1199.
11. sm, or HIV-2 infection in cynomolgus monkeys by pre- and postexposure administration of BEA-005. AIDS. 1997;11:157-162.
12. Centers for Disease Control and Prevention. Case control study of HIV conversion in health care workers after percutaneous exposure to HIV infected blood: France, United Kingdom, and US, January 1988-August 1994. MMWR Morb Mortal Wkly Rep. 1997;44:929-933.
13. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal infant transmission of human immunodeficiency virus type I with zidovudine treatment. N Engl J ed. 1994;31:1173-1180.
14. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomized trial. Lancet. 1999; 354:795-802.
15. Tokars JI, Marcus R, Culver DH, et al. Surveillance of HIV infection and zidovudine use among health care workers alter occupational exposure to HIV infected blood. Ann Intern Med. 1993;118:913-919.
16. Downs AM, DeVincenzi I. Probability of heterosexual transmission of HIV: relationship to the number of unprotected sexual contacts. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;11:388-395.
17. Albert J, Wahlberg J, Leitner T, et al. Analysis of a rape case by direct sequencing of the human immunodeficiency virus type 1 pol and gag genes. J Virol. 1994; 68:5918-5924.
18. Montella F, Recchia O. Can HIV-1 infection be transmitted by a "discarded" syringe [letter]? J Acquir Immune Defic Syndr. 1992;5:1274-1275.
19. Abdala N, Stephens PC, Griffith BP, Heimer R. Survival of HIV-1 in syringes. J Acquir Immune Defic Syndr Hum Retrovirol. 1999;20:73-80.